The #addiction treatment and prevention field’s clinical #b2b news source outlining what’s working in services for people with addictive disorders. #sobriety
A recent meta-analysis of 10 longitudinal studies conducted by Yale University researchers found no significant link between cannabis use and relapse on non-medical opioids among patients receiving medication-assisted treatment for OUD.
https://t.co/8fgFhZFCVY
Allegheny Health Network seeks 2 additional patients for a trial in which patients with treatment-resistant opioid use disorder receive continuous electrical pulses to the brain’s addiction and reward center to curb severe cravings.
https://t.co/6ip8mDm3hP
Findings from a recent study conducted by researchers at the Medical University of South Carolina suggest that N-acetylcysteine (NAC) may help decrease surgery patients’ pain levels and use of opioids.
https://t.co/kKmPmO2qTx
The Centers for Medicare & Medicaid Services have introduced a new initiative aimed at advancing the integration of behavioral and physical healthcare, as well as health-related social needs, for people with Medicaid and Medicare.
https://t.co/95eEFCjZDV
New research from Oregon Health & Science University highlights challenges related to finding residential addiction treatment for adolescents, with medication-assisted treatment options especially scarce.
https://t.co/1YYcVMBSEp
Reducing use of stimulants was associated with significant improvement in health and recovery among individuals with stimulant use disorder—even if they did not achieve total abstinence, according to a new study from NIDA.
https://t.co/sFf46I3di8
The AvertD test, developed by AutoGenomics, Inc., is designed for consenting patients at least 18 years of age who are being considered for an opioid prescription of 4 to 30 days.
https://t.co/LhXPPjGYft
While prescribing of opioid-containing pain relief medications for surgery patients has declined over the past 7 years, a recent study of pharmacy data by researchers at the University of Michigan shows that decrease has slowed since 2020.
https://t.co/XLKRPVgpi0
Delix Therapeutics has been awarded a $320,000 grant from the National Institute on Drug Abuse to support the advancement of its novel neuroplastogen and non-hallucinogenic ibogaine analog, DLX-007.
https://t.co/TcAMfDiZNG
A behavioral intervention that integrates mindfulness, emotion regulation, and savoring of natural rewards could help reduce relapse rates in women receiving MAT for OUD, according to new research from Rutgers University.
https://t.co/1MTT9nQ7Bu
While Monitoring the Future survey data show adolescent past-year use rates are down, NIDA researchers caution that the emergence of illicit fentanyl has disproportionately driven up teen overdose deaths.
https://t.co/OdjNsAje2y
Oral nicotine pouches, an increasingly popular, smoke-free and tobacco-free alternative to cigarettes, do little to curb current smokers’ nicotine cravings, according to a recent study.
https://t.co/n6KzXdSo2e
A reformulation of the prescription opioid OxyContin that caused users to seek illicit alternatives led to an increase in rates of child neglect and altered living arrangements, which, in part, fueled an increase in child suicides, according to RAND.
https://t.co/LeugcQ61mq
BrightView Chief Clinical Officer Melissa Sahlin, LISW-S, LCSW, explains how practitioners can improve virtual-based therapy by using the right equipment and familiarizing patients with their telehealth platform.
https://t.co/zntFtVGoBn
Drug overdose deaths among women and girls between the ages of 10 and 44 who were pregnant or pregnant within the past 12 months soared from 2018 to 2021, according to a NIDA study.
https://t.co/Sivz1dLyyC
Andrew Tatarsky, PhD, defines the 4 principles of harm reduction and explains why integrative harm reduction psychotherapy can appeal to patients who are resistant to an abstinence-based approach at the outset of recovery.
https://t.co/tykajUwT6f
About 1 in 4 people in the US who are at least 12 years of age used illicit drugs within the past year and more than 1 in 6 had a substance use disorder during the same period, according to data from the latest National Survey on Drug Use and Health.
https://t.co/s3ymsr7cu1
Often associated with treatment for stimulant addiction, contingency management programs can work as a complement to medication-assisted treatment for other substance use disorders as well, says Steven Proctor, PhD.
https://t.co/vx25c3Yjl6
A clinical trial conducted by NIDA researchers has found that a group of brain regions is activated after a drug is taken intravenously, but not when the same drug is taken orally.
https://t.co/0U2I6l0FNP
Researchers from West Virginia University and the University of Virginia are studying the use of low-intensity focused ultrasound as an intervention to reduce cravings for multiple substances.
https://t.co/Q8h9eYIrIZ